Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209296

CINVANTI (APREPITANT)
130MG/18ML (7.2MG/ML) Marketing Status: Prescription

Active Ingredient: APREPITANT
Proprietary Name: CINVANTI
Dosage Form; Route of Administration: EMULSION; INTRAVENOUS
Strength: 130MG/18ML (7.2MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209296
Product Number: 001
Approval Date: Nov 9, 2017
Applicant Holder Full Name: HERON THERAPEUTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English